VolitionRX Limited (NYSEAMERICAN:VNRX - Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.68 and traded as low as $0.60. VolitionRX shares last traded at $0.61, with a volume of 242,374 shares trading hands.
VolitionRX Stock Up 4.5%
The firm's 50 day moving average is $0.67. The firm has a market cap of $70.60 million, a PE ratio of -2.62 and a beta of 1.27.
About VolitionRX
(
Get Free Report)
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Recommended Stories
Before you consider VolitionRX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VolitionRX wasn't on the list.
While VolitionRX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
